Editorial: Immunology of cachexia

被引:0
作者
Kumar, Vijay [1 ]
Stewart, John H. [1 ]
机构
[1] Morehouse Sch Med, Dept Surg, Lab Tumor Immunol & Immunotherapy, Atlanta, GA 30310 USA
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
关键词
cachexia; immunity; inflammation; NLRP3; inflammasome; cancer; immune-checkpoint inhibitors; NLRP3; INFLAMMASOME; CANCER CACHEXIA; GLYCOLYSIS;
D O I
10.3389/fimmu.2023.1339263
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页数:4
相关论文
共 36 条
  • [21] B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5
    Legler, DF
    Loetscher, M
    Roos, RS
    Clark-Lewis, I
    Baggiolini, M
    Moser, B
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (04) : 655 - 660
  • [22] Type 2 immunity is maintained during cancer-associated adipose tissue wasting
    Lenehan, Patrick J.
    Cirella, Assunta
    Uchida, Amiko M.
    Crowley, Stephanie J.
    Sharova, Tatyana
    Boland, Genevieve
    Dougan, Michael
    Dougan, Stephanie K.
    Heckler, Max
    [J]. IMMUNOTHERAPY ADVANCES, 2021, 1 (01):
  • [23] PKM2-dependent glycolysis promotes skeletal muscle cell pyroptosis by activating the NLRP3 inflammasome in dermatomyositis/polymyositis
    Liu, Di
    Xiao, Yizhi
    Zhou, Bin
    Gao, Siming
    Li, Liya
    Zhao, Lijuan
    Chen, Weilin
    Dai, Bingying
    Li, Qiuxiang
    Duan, Huiqian
    Zuo, Xiaoxia
    Luo, Hui
    Zhu, Honglin
    [J]. RHEUMATOLOGY, 2021, 60 (05) : 2177 - 2189
  • [24] Association between Platelet Count with 1-year Survival in Patients with Cancer Cachexia
    Liu, Yuying
    Ge, Yizhong
    Li, Qinqin
    Ruan, Guotian
    Zhang, Qi
    Zhang, Xi
    Tang, Meng
    Song, Mengmeng
    Zhang, Xiaowei
    Li, Xiangrui
    Zhang, Kangping
    Yang, Ming
    Hu, Chunlei
    Liu, Tong
    Xie, Hailun
    Chen, Yongbing
    Yu, Kaiying
    Cong, Minghua
    Li, Wei
    Wang, Zhengping
    Shi, Hanping
    [J]. JOURNAL OF CANCER, 2021, 12 (24): : 7436 - 7444
  • [25] Desensitizing Effect of Cancer Cachexia on Immune Checkpoint Inhibitors in Patients With Advanced NSCLC
    Miyawaki, Taichi
    Naito, Tateaki
    Kodama, Akihro
    Nishioka, Naoya
    Miyawaki, Eriko
    Mamesaya, Nobuaki
    Kawamura, Takahisa
    Kobayashi, Haruki
    Omori, Shota
    Wakuda, Kazushige
    Ono, Akira
    Kenmotsu, Hirotsugu
    Murakami, Haruyasu
    Notsu, Akifumi
    Mori, Keita
    Harada, Hideyuki
    Endo, Masahiro
    Takahashi, Kazuhisa
    Takahashi, Toshiaki
    [J]. JTO CLINICAL AND RESEARCH REPORTS, 2020, 1 (02):
  • [26] High platelet count as a link between renal cachexia and cardiovascular mortality in end-stage renal disease patients
    Molnar, Miklos Z.
    Streja, Elani
    Kovesdy, Csaba P.
    Budoff, Matthew J.
    Nissenson, Allen R.
    Krishnan, Mahesh
    Anker, Stefan D.
    Norris, Keith C.
    Fonarow, Gregg C.
    Kalantar-Zadeh, Kamyar
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2011, 94 (03) : 945 - 954
  • [27] Radiomics predicts risk of cachexia in advanced NSCLC patients treated with immune checkpoint inhibitors
    Mu, Wei
    Katsoulakis, Evangelia
    Whelan, Christopher J.
    Gage, Kenneth L.
    Schabath, Matthew B.
    Gillies, Robert J.
    [J]. BRITISH JOURNAL OF CANCER, 2021, 125 (02) : 229 - 239
  • [28] Muscle wasting in chronic kidney disease
    Oliveira, Eduardo A.
    Cheung, Wai W.
    Toma, Kalodiah G.
    Mak, Robert H.
    [J]. PEDIATRIC NEPHROLOGY, 2018, 33 (05) : 789 - 798
  • [29] Role of NLRP-3 Inflammasome in Hypertension: A Potential Therapeutic Target
    Pasqua, Teresa
    Pagliaro, Pasquale
    Rocca, Carmine
    Angelonel, Tommaso
    Penna, Claudia
    [J]. CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2018, 19 (09) : 708 - 714
  • [30] TNF-α and cancer cachexia: Molecular insights and clinical implications
    Patel, Hetal J.
    Patel, Bhoomika M.
    [J]. LIFE SCIENCES, 2017, 170 : 56 - 63